Forgot your password? Enter your registered email address below to initiate a password reset.
Assistant Professor of Neurological Surgery
Andrew Ducruet, MD, joined the Department of Neurological Surgery as an assistant professor on July 8, 2013. Dr. Ducruet’s clinical practice focuses on cerebrovascular disease, and he has subspecialized training in the latest endovascular techniques used to treat patients with vascular disease of both the brain and spinal cord. This includes both coil embolization and flow diversion strategies for the treatment of cerebral aneurysms, as well as embolization of arteriovenous malformations, arteriovenous fistulas, and tumors. He also performs arterial and venous stenting procedures, and treats patients with acute ischemic stroke.
Dr. Ducruet was born and raised in the Pittsburgh area. He received his undergraduate degree from Princeton University, and his medical degree from Columbia University’s College of Physicians & Surgeons. He completed his surgical internship and residency in neurological surgery at New York Presbyterian Hospital/Columbia University Medical Center. Dr. Ducruet then completed a two-year fellowship in endovascular neurosurgery at the Barrow Neurological Institute in Phoenix, AZ.
Dr. Ducruet's publications can be reviewed through the National Library of Medicine's publication database.
Children’s Hospital of Pittsburgh of UPMC
American Association of Neurological Surgeons
American Heart Association/ American Stroke Association
Congress of Neurological Surgeons
Society of Neurointerventional Surgery
Dr. Ducruet conducts both clinical and basic/translational research focused on cerebrovascular disease, and has published over 70 papers in peer-reviewed journals as well as numerous book chapters. He has been a co-investigator on multiple clinical trials evaluating novel endovascular strategies for the treatment of cerebral aneurysms and acute ischemic stroke. Dr. Ducruet also directs a translational stroke research laboratory. His laboratory investigates the role of inflammation and complement activation following cerebral ischemia in the hopes of identifying new targets for therapeutic intervention for stroke